Health Condition 1: - Health Condition 2: J988- Other specified respiratory disorders Health Condition 3: null- Transient tachypnea of newborn
Conditions
Interventions
Intervention1: Inhaled beta-2 agonist use in treatment of transient tachypnea of newborn: Salbutamol will be given as one nebulized dose in patients randomized to receive treatment as standard dose of
one dose will be administered over the course of 20 minutes.
Control Intervention1: Standard treatment for transient tachypnea of newborn: Nasal continuous positive airway pressure with oxygen and int
Sponsors
St Stephens Hospital
Dr pinky bahl
Eligibility
Inclusion criteria
Inclusion criteria: 1. Neonates more than 34 weeks diagnosed as transient tachypnea of newborn according to: - symptoms within first 6 hours after birth - x-ray chest consistent with retained fetal lung fluid
Exclusion criteria
Exclusion criteria: 1.premature infants less than 35 weeks 2. Neonates with meconium aspiration syndrome or septecemia 3.neonates with hyaline memberane disease 4.neonates with birth asphyxia 5. Neonates with congenital heart disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate improvement in respiratory distress based on respiratory rate and TTN scoreTimepoint: To evaluate improvement in respiratory distress based on respiratory rate and TTN score | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate duration of Hospitalization in salbutamol treated group compared to standard treatment groupTimepoint: 72 hours;To evaluate oxygen requirement in salbutamol treated group as compared to standard treatment groupTimepoint: 0 hour, 1 hour and 4th hour;To evaluate type and duration of respiratory support required in salbutamol treated group as compared to standard treatment groupTimepoint: 72 hours | — |
Countries
India
Contacts
Public ContactDr Jacob Puliyel
St.stephens Hospital Tis Hazari new delhi-110054
Outcome results
None listed